XML 42 R26.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business Combinations (Tables)
12 Months Ended
Dec. 31, 2016
Business Acquisition [Line Items]  
Summary of assets and liabilities included in the accompanying consolidated balance sheet

Total assets and liabilities of Progentix included in the accompanying Consolidated Balance Sheets are as follows (in thousands):

 

 

December 31,

 

 

 

2016

 

 

2015

 

Total current assets

 

$

334

 

 

$

353

 

Identifiable intangible assets, net

 

 

10,900

 

 

 

13,048

 

Goodwill

 

 

12,654

 

 

 

12,654

 

Accounts payable & accrued expenses

 

 

551

 

 

 

574

 

Deferred tax liabilities, net

 

 

880

 

 

 

1,496

 

Non-controlling interests

 

 

5,588

 

 

 

7,309

 

 

Reconciliation of equity attributable to the non-controlling interests

The following is a reconciliation of equity attributable to the non-controlling interests (in thousands): 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2015

 

Non-controlling interests at beginning of period

 

$

7,309

 

 

$

8,310

 

Less: Net (loss) attributable to the non-controlling interests

 

 

(1,721

)

 

 

(1,001

)

Non-controlling interests at end of period

 

$

5,588

 

 

$

7,309

 

 

Ellipse Technologies Inc [Member]  
Business Acquisition [Line Items]  
Schedule of allocation for purchase price to the assets acquired and liabilities assumed based on fair values

The Company applied certain assumptions and findings in the valuation outcome for the assets acquired and liabilities assumed, for which the allocation of the purchase price is based on the fair values, as follows:

(in thousands)

 

 

 

 

Cash paid for purchase

 

$

381,579

 

 

 

 

 

 

Accounts receivable

 

 

7,148

 

Inventory

 

 

22,451

 

Other current assets

 

 

1,855

 

Property, plant and equipment, net

 

 

6,725

 

Definite-lived intangible assets:

 

 

 

 

Developed technology

 

 

133,900

 

Customer relationships

 

 

33,200

 

Trade names

 

 

16,200

 

Goodwill

 

 

241,905

 

Deferred tax assets

 

 

18,471

 

Other assets

 

 

1,868

 

Contingent consideration liability

 

 

18,800

 

Deferred tax liabilities

 

 

75,160

 

Other liabilities assumed

 

 

8,184

 

 

 

 

 

 

 

 

$

381,579

 

 

Schedule of unaudited pro forma financial information

The following table presents the unaudited pro forma results for the years ended December 31, 2016 and December 31, 2015. The unaudited pro forma financial information combines the results of operations of NuVasive and Ellipse Technologies as though the companies had been combined as of January 1, 2015, and the unaudited pro forma information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at such times. The unaudited pro forma results presented include non-recurring adjustments directly attributable to the business combination, some of which are presented in the comparable period results instead of the current period by nature of such adjustments. The adjustments for amortization charges for acquired intangible assets were $26.0 million for the year ended December 31, 2015. The adjustments to cost of sales for increased fair value of acquired inventory of $(14.7) million and $14.7 million for the years ended December 31, 2016 and December 31, 2015, respectively, were amortized over the period in which underlying products were sold. The year ended December 2015 also includes an adjustment of $4.0 million for acquisition related expenses. Additionally, the years ended December 31, 2016 and 2015 include immaterial adjustments to revenue for deferred revenue adjustments, and related tax effects to the pre-tax income. The pre-acquisition accounting policies of Ellipse Technologies were materially similar to the Company, with the differences adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented.

 

 

Years Ended December 31,

 

 

 

2016

 

 

2015

 

(in thousands, except per share amounts)

 

(unaudited)

 

 

(unaudited)

 

Revenues

 

$

968,179

 

 

$

854,673

 

Net income attributable to NuVasive, Inc.

 

 

38,045

 

 

 

11,675

 

Net income per share attributable to NuVasive, Inc.:

 

 

 

 

 

 

 

 

Basic

 

$

0.76

 

 

$

0.24

 

Diluted

 

$

0.70

 

 

$

0.22